RxDoctor Payments Data

Maureen Geary, NP

Nurse Practitioner · Buffalo, NYNPI 1912925686

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $12,080 of the $16,185 with a category attached, or 74.6%. Alnylam Pharmaceuticals Inc. accounts for 95.7% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2024 at $12,167 and has fallen 71.6% since, to $3,459 in 2025. Among nurse practitioner clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$16,185in general payments, 2019–2025

Across 51 payments — averaging $317.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alnylam Pharmaceuticals Inc.$15K
  • AstraZeneca$256
  • Johnson & Johnson$164
  • Boehringer Ingelheim$125
  • Pfizer$68
  • Merck$41
  • plus $46 from 2 others

What the payments were for

  • Speaking & faculty fees$12,08075%
  • Travel & lodging$2,57416%
  • Food & beverage$1,5309%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,185 in reported general payments places this provider in the 95th percentile of 4,112 nurse practitioner providers in New York.

See all nurse practitioner providers in New York

Medicare billing

Part B allowed, 2024
$16,884
Medicare patients
111
Services billed
150

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nurse practitioner in Buffalo

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →